Trial intelligence / Profile preview

DPK-060 in Atopic Dermatitis

NCT01522391Phase 2Completed

Start
Mar 2008
Primary completion
Apr 2009
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of DPK-060 in atopic dermatitis (AD). Started Mar 2008; status: completed.

02

Drugs

DPK-060
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT01522391.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01522391.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call